OPIOID MAINTENANCE TREATMENT AS A HARM REDUCTION TOOL FOR OPIOID-DEPENDENT INDIVIDUALS IN NEW YORK CITY: THE NEED TO EXPAND ACCESS TO BUPRENORPHINE/NALOXONE IN MARGINALIZED POPULATIONS

被引：64

作者：

Stancliff, Sharon ^{[1
]}

Joseph, Herman ^{[2
,3
]}

Fong, Chunki ^{[4
]}

Furst, Terry ^{[5
]}

Comer, Sandra D. ^{[6
]}

Roux, Perrine ^{[6
,7
]}

机构：

[1] Harm Reduct Coalit, New York, NY 10025 USA

[2] New York State Off Alcoholism & Subst Abuse Serv, New York, NY USA

[3] Rockefeller Univ, New York, NY 10021 USA

[4] Natl Dev & Res Inst Inc, New York, NY USA

[5] City Univ NY, John Jay Coll Criminal Justice, New York, NY USA

[6] Columbia Univ, Subst Use Res Ctr, NYSPI, New York, NY USA

[7] INSERM, U912 SE4S, Marseilles, France

来源：

JOURNAL OF ADDICTIVE DISEASES | 2012年 / 31卷 / 03期

关键词：

Buprenorphine; heroin; harm reduction; drug treatment; opioid; METHADONE TREATMENT; TREATMENT PROGRAMS; PUBLIC-HEALTH; UNITED-STATES; HEROIN; USERS; CARE; PARTICIPATION; EXPERIENCE; ADDICTION;

D O I：

10.1080/10550887.2012.694603

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

The aim of this pilot study was to assess the effectiveness of buprenorphine/naloxone (BUP/NX) among marginalized, opioid-dependent individuals in terms of retention in and cycling into and out of a harm-reduction program. This pilot study enrolled 100 participants and followed them from November 2005 to July 2008. The overall proportion of patients retained in the program at the end of 3, 6, 9, and 12 months was 68%, 63%, 56%, and 42%, respectively. This pilot study demonstrated that BUP/NX could be successfully used to treat marginalized heroin users.

引用

页码：278 / 287

页数：10

共 3 条

[1] No Increase in Chronic Pain Among Opioid-Dependent Individuals Randomized to Treatment With Extended-Release Naltrexone Compared to Buprenorphine-Naloxone
Tanum, Lars
Latif, Zill-E-Huma
Solli, Kristin
Opheim, Arild
Kunoe, Nikolaj
Benth, Jurate
Krajci, Peter
BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S211 - S212
[2] Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study
Parkin, Stephen
Neale, Joanne
Brown, Caral
Campbell, Aimee N. C.
Castillo, Felipe
Jones, Jermaine D.
Strang, John
Comer, Sandra D.
INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 79
[3] No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study
Latif, Zill-e-Huma
Solli, Kristin K.
Opheim, Arild
Kunoe, Nikolaj
Benth, Jurate S.
Krajci, Peter
Sharma-Haase, Kamni
Tanum, Lars
AMERICAN JOURNAL ON ADDICTIONS, 2019, 28 (02) : 77 - 85

← 1 →